Zyprexa is the Eli-Lilly Company trade name for the drug called Olanzapine. Zyprexa is an atypical antipsychotic drug prescribed for the treatment of schizophrenia, bi-polar disorder, and other psychiatric disorders. Zyprexa has been on the market since 1996 and is used by over 14 million patients worldwide. Zyprexa is Eli-Lilly Company's best selling drug with global sales reportedly close to $4 billion per year and more than 7 million prescriptions written annually.
If you or someone you know has taken Zyprexa and developed accelerated weight gain, diabetes, or pancreatitis, please contact us for additional information and a review of your case. You may be entitled to compensation for injury caused by Zyprexa.
Please
contact us with any questions or if you'd like to explore your legal rights.
